Marker | Study | Study design | Nb of patients, n | Level of evidence | Biomarker tested and groups compared | Main results |
---|---|---|---|---|---|---|
1 st author, [Ref] | ||||||
PCT/CRP | Rau B, [2] | Observational | 61 | Low | Comparison of PCT and CRP levels between 3 groups: | AUROC for the diagnosis of infected necrosis: |
Oedematous pancreatitis (n = 22) | PCT (>1.8 mg/L) = 0.95 (Se: 95%, Sp: 88%), | |||||
Sterile necrosis (n = 18) | CRP (>300 mg/L) = 0.86 (Se:86%, Sp: 75%); p < 0.02 | |||||
Infected necrosis (n = 21) according to imaging/surgery/microbiological data | ||||||
PCT/CRP/GCSF | Muller CA, [3] | Observational | 64 | Low | Comparison of PCT, G-CSF, and CRP between patients having oedematous pancreatitis (n = 29) | AUROC for diagnosing infected necrosis: |
CRP (>250) = 0.79 (Se: 83, Sp: 70%), PCT (0.45) = 0.77 (Se: 92%, Sp: 65%), AUC G-CSF (101) = 0.72 (Se: 92%, Sp: 48%) | ||||||
Noninfected necrosis (n = 23) | ||||||
Infected necrosis (n = 12) according to imaging/surgery/microbiological data | ||||||
PCT/CRP/IL8 | Rau B, [4] | Observational | 50 | Low | Comparison of PCT, IL8, and CRP levels between patients with: | AUROC for diagnosing infected necrosis: |
Oedematous pancreatitis (n = 18) | CRP (>300) = 0.84 (Se: 83, Sp: 78%), | |||||
Non-infected necrosis (n = 14) | PCT (>1.8) = 0.97 (Se: 94%, Sp: 90%) | |||||
Infected necrosis (n = 18) according to imaging/surgery/microbiological data | IL-8 (112) = 0.78 (Se: 72%, Sp: 75%) | |||||
PCT/CRP/IL6/TNF | Riche F, [5] | Observational | 48 | Low | Comparison of PCT, IL-6, TNF-α, and CRP between patients having | AUROC for diagnosing infected necrosis: |
- Noninfected necrosis (n = 33) | CRP = 0.76, | |||||
- Infected necrosis (n = 15), according to imaging/surgery/microbiological data | PCT = 0.78, | |||||
IL 6 = 0.77, | ||||||
TNF α = 0.5 | ||||||
PCT | Purkayastha S, [6] | Literature review (5 studies) | 206 | Low | Assessing the value of PCT for diagnosing infected pancreatic necrosis | Threshold values for PCT vary from 0.48 to 2; |
Sensitivity: 0.73 to 0.94 | ||||||
Specificity: 0.65 to 1 | ||||||
PCT/IL6/TNF/sTREM1 | Lu Z, [7] | Observational | 30 | Low | Comparison of PCT, IL-6, TNF-α, and sTREM-1 levels in serum and drainage fluid between patients having: | Biomarker levels in drainage fluid: No difference between the two groups for CRP, TNF-α, and IL-6 levels |
- Noninfected necrosis (n = 12), or | - sTREM1 (287), AUC = 0.97 (Se = 94, Sp = 92) | |||||
- Infected necrosis (n = 18), according to imaging/surgery/microbiological data | - PCT (2.1): AUC = 0.9 (Se = 86, Sp = 91). | |||||
Lower AUCs for serum levels: | ||||||
PCT: 0.79; sTREM1: 0.73 | ||||||
PCT | Olah A, [8] | Observational | 24 | Low | Comparison of PCT levels in patients having | Serum PCT level >0.5 predicts infected necrosis with Se = 75% and Sp = 83%. |
- Noninfected necrosis (n = 12) | Fine-needle aspiration predicts infection with Se = 92% and Sp = 100%. | |||||
- Infected necrosis (n = 12) | ||||||
According to results of fine-needle aspiration and culture and surgery | ||||||
PCT/IL6/sICAM1 | Mandi Y, [9] | Observational | 30 | Low | Comparison of PCT, IL-6, and sICAM-1 between patients with | Only PCT (threshold >1 mg/L) allowed to distinguish patients with or without infected necrosis (Se = 90%; Sp = 100%). |
Noninfected necrosis (n = 10) | ||||||
Infected necrosis (n = 10), according to results of biopsy and culture. | ||||||
PCT | Mofidi R, [1] | Literature review (7 studies) | 264 | Low | Assessment of PCT serum levels for the diagnosis of infected pancreatic necrosis | Threshold values vary from 0.48 to 3.5 mg/L, with a sensitivity of 0.63 to 0.92 and specificity of 0.71 to 0.97. |
Summary table: infected necrosis in acute pancreatitis | ||||||
Number of studies, n | Total number of patients, n | Highest level of evidence | Directness* | Consistency of results** | Overall strength of evidence | |
7 | 264a | Low | Yes | Â | Yes | Moderate |